Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Risk of thrombosis with anomalies of the inferior vena cava and factor V Leiden.

Sánchez Fernández GL, Reiss UM, de Alarcón PA.

Pediatr Blood Cancer. 2008 Mar;50(3):731. Review. No abstract available.

PMID:
17514740
2.

[A case report of posttraumatic deep vein thrombosis of the lower limbs in a patient with factor V Leiden mutation and the congenital absence of the inferior vena cava].

Jendrzejewski J, Gockowski K, Jasiel-Wojculewicz H, Zapaśnik A, Kulczycka J, Wyrzykowski B.

Pol Arch Med Wewn. 2006 Apr;115(4):345-50. Polish.

PMID:
17078493
3.

Deep venous thrombosis caused by congenital malformation of the inferior vena cava and heterozygous factor V leiden presenting as venous claudication.

Fass G, Nasroolah D, Cavenaile JC.

Clin Appl Thromb Hemost. 2009 Oct;15(5):591-5. doi: 10.1177/1076029608324928. Epub 2008 Nov 2.

PMID:
18980946
4.

Abdominal nodules as a presentation of obstruction of the inferior vena cava and factor V Leiden mutation.

García-Doval I, Losada A, de La Torre C, González A, Cruces MJ.

J Am Acad Dermatol. 2000 May;42(5 Pt 2):862-4.

PMID:
10767687
5.

Images in cardiovascular medicine. Hughes-Stovin syndrome.

Kindermann M, Wilkens H, Hartmann W, Schäfers HJ, Böhm M.

Circulation. 2003 Dec 9;108(23):e156. No abstract available.

6.

[Agenesis of inferior vena cava combined with multiple genetic predisposition in the case of deep venous thrombosis in a young male].

Vidra T, Szomor A, Battyáni I, Mühl D, Losonczy H.

Orv Hetil. 2003 Nov 16;144(46):2283-6. Hungarian.

PMID:
14702924
7.

Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers.

Morange PE, Aillaud MF, Nicaud V, Henry M, Juhan-Vague I.

Thromb Haemost. 2001 Dec;86(6):1583-4. No abstract available.

PMID:
11776333
8.

Double heterozygosity for Factor V Leiden and Factor V Cambridge mutations associated with low levels of activated protein C resistance in a Spanish thrombophilic family.

Santamaría A, Soria JM, Tirado I, Mateo J, Coll I, Souto JC, Fontcuberta J.

Thromb Haemost. 2005 Jun;93(6):1193-5. No abstract available.

PMID:
15968408
9.
10.

In the presence of other inherited or acquired high-risk situations, the FV Cambridge mutation may be an additional thrombophilic risk factor, through its effect on APC sensitivity.

Santacroce R, Bossone A, Brancaccio V, Fortina P, Margaglione M.

Thromb Haemost. 2000 Jun;83(6):963-4. No abstract available.

PMID:
10896257
11.

Cardiology patient page. Factor V Leiden.

Ornstein DL, Cushman M.

Circulation. 2003 Apr 22;107(15):e94-7. No abstract available.

12.

Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism?

Aras O, Hanson NQ, Tsai MY, Key NS.

Thromb Haemost. 2002 Jan;87(1):173-4. No abstract available.

PMID:
11848451
13.

[Prevention of thrombosis in genetic susceptibility? Thrombosis ABC: APC resistance].

Stiefelhagen P.

MMW Fortschr Med. 1999 Sep 2;141(35):44. German. No abstract available.

PMID:
10897957
14.

Prevalence of factor V Leiden mutation in Yugoslav thrombophilic patients and its relationship to the laboratory diagnosis of APC resistance.

Mikovic D, Rakicevic L, Kovac M, Radojkovic D.

Thromb Haemost. 2000 Oct;84(4):723-4. No abstract available.

PMID:
11057877
15.

[Is lifetime anticoagulation required in factor V Leiden mutation?].

Pötzsch B.

Dtsch Med Wochenschr. 2003 Jul 25;128(30):1617. German. No abstract available.

PMID:
12884152
16.

A dangerous combination: Fabry disease and factor V Leiden.

Niemann M, Weidemann F.

Intern Med J. 2012 Nov;42(11):1270-1. doi: 10.1111/j.1445-5994.2012.02954.x. No abstract available.

PMID:
23157526
17.
18.

Discrepancy between phenotype and genotype on screening for factor V Leiden after transplantation.

Parker J, Pagliuca A, Kitiyakara T, Whitehead M, Heaton N, O'Grady J, Arya R.

Blood. 2001 Apr 15;97(8):2525-6. No abstract available.

19.

[APC resistance--most frequent familial thrombophilia].

Herren S, Lämmle B.

Ther Umsch. 1999 Sep;56(9):499-501. German.

PMID:
10517118
20.

Massive deep venous thrombosis, congenital interruption of the inferior vena cava and heterozygosity for factor V Leiden.

Molina MA, Giménez MJ, Giménez F, Ramos JA, Avivar C.

Thromb Haemost. 2000 Dec;84(6):1121-2. No abstract available.

PMID:
11154126
Items per page

Supplemental Content

Write to the Help Desk